The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.
The global Tumor Ablation market size is expected to reach US$ 1088.9 million by 2029, growing at a CAGR of 10.5% from 2023 to 2029. The market is mainly driven by the significant applications of Tumor Ablation in various end use industries. The expanding demands from the Liver Cancer, Lung Cancer, Kidney Cancer and Others, are propelling Tumor Ablation market. Radiofrequency (RF) Ablation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microwave Ablation segment is estimated at % CAGR for the next seven-year period.
Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.
North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tumor Ablation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tumor Ablation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tumor Ablation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tumor Ablation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tumor Ablation covered in this report include Angiodynamics, Medtronic, Boston Scientific, Misonix, Sonacare Medical, EDAP TMS, Chongqing Haifu Medical, HealthTronics and J &J, etc.
The global Tumor Ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Angiodynamics
- Medtronic
- Boston Scientific
- Misonix
- Sonacare Medical
- EDAP TMS
- Chongqing Haifu Medical
- HealthTronics
- J &J
Global Tumor Ablation market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tumor Ablation market, Segment by Type:
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryoablation
- Other Technologies
Global Tumor Ablation market, by Application
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tumor Ablation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Tumor Ablation Market Overview
1.1 Tumor Ablation Product Overview
1.2 Tumor Ablation Market Segment by Type
1.2.1 Radiofrequency (RF) Ablation
1.2.2 Microwave Ablation
1.2.3 Cryoablation
1.2.4 Other Technologies
1.3 Global Tumor Ablation Market Size by Type
1.3.1 Global Tumor Ablation Market Size Overview by Type (2018-2029)
1.3.2 Global Tumor Ablation Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tumor Ablation Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tumor Ablation Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tumor Ablation Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tumor Ablation Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tumor Ablation Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tumor Ablation Sales Breakdown by Type (2018-2023)
2 Global Tumor Ablation Market Competition by Company
2.1 Global Top Players by Tumor Ablation Sales (2018-2023)
2.2 Global Top Players by Tumor Ablation Revenue (2018-2023)
2.3 Global Top Players by Tumor Ablation Price (2018-2023)
2.4 Global Top Manufacturers Tumor Ablation Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tumor Ablation Market Competitive Situation and Trends
2.5.1 Tumor Ablation Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tumor Ablation Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Ablation as of 2022)
2.7 Date of Key Manufacturers Enter into Tumor Ablation Market
2.8 Key Manufacturers Tumor Ablation Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tumor Ablation Status and Outlook by Region
3.1 Global Tumor Ablation Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tumor Ablation Historic Market Size by Region
3.2.1 Global Tumor Ablation Sales in Volume by Region (2018-2023)
3.2.2 Global Tumor Ablation Sales in Value by Region (2018-2023)
3.2.3 Global Tumor Ablation Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tumor Ablation Forecasted Market Size by Region
3.3.1 Global Tumor Ablation Sales in Volume by Region (2024-2029)
3.3.2 Global Tumor Ablation Sales in Value by Region (2024-2029)
3.3.3 Global Tumor Ablation Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tumor Ablation by Application
4.1 Tumor Ablation Market Segment by Application
4.1.1 Liver Cancer
4.1.2 Lung Cancer
4.1.3 Kidney Cancer
4.1.4 Others
4.2 Global Tumor Ablation Market Size by Application
4.2.1 Global Tumor Ablation Market Size Overview by Application (2018-2029)
4.2.2 Global Tumor Ablation Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tumor Ablation Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tumor Ablation Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tumor Ablation Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tumor Ablation Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tumor Ablation Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tumor Ablation Sales Breakdown by Application (2018-2023)
5 North America Tumor Ablation by Country
5.1 North America Tumor Ablation Historic Market Size by Country
5.1.1 North America Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tumor Ablation Sales in Volume by Country (2018-2023)
5.1.3 North America Tumor Ablation Sales in Value by Country (2018-2023)
5.2 North America Tumor Ablation Forecasted Market Size by Country
5.2.1 North America Tumor Ablation Sales in Volume by Country (2024-2029)
5.2.2 North America Tumor Ablation Sales in Value by Country (2024-2029)
6 Europe Tumor Ablation by Country
6.1 Europe Tumor Ablation Historic Market Size by Country
6.1.1 Europe Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tumor Ablation Sales in Volume by Country (2018-2023)
6.1.3 Europe Tumor Ablation Sales in Value by Country (2018-2023)
6.2 Europe Tumor Ablation Forecasted Market Size by Country
6.2.1 Europe Tumor Ablation Sales in Volume by Country (2024-2029)
6.2.2 Europe Tumor Ablation Sales in Value by Country (2024-2029)
7 Asia-Pacific Tumor Ablation by Region
7.1 Asia-Pacific Tumor Ablation Historic Market Size by Region
7.1.1 Asia-Pacific Tumor Ablation Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tumor Ablation Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tumor Ablation Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tumor Ablation Forecasted Market Size by Region
7.2.1 Asia-Pacific Tumor Ablation Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tumor Ablation Sales in Value by Region (2024-2029)
8 Latin America Tumor Ablation by Country
8.1 Latin America Tumor Ablation Historic Market Size by Country
8.1.1 Latin America Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tumor Ablation Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tumor Ablation Sales in Value by Country (2018-2023)
8.2 Latin America Tumor Ablation Forecasted Market Size by Country
8.2.1 Latin America Tumor Ablation Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tumor Ablation Sales in Value by Country (2024-2029)
9 Middle East and Africa Tumor Ablation by Country
9.1 Middle East and Africa Tumor Ablation Historic Market Size by Country
9.1.1 Middle East and Africa Tumor Ablation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tumor Ablation Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tumor Ablation Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tumor Ablation Forecasted Market Size by Country
9.2.1 Middle East and Africa Tumor Ablation Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tumor Ablation Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Angiodynamics
10.1.1 Angiodynamics Company Information
10.1.2 Angiodynamics Introduction and Business Overview
10.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Angiodynamics Tumor Ablation Products Offered
10.1.5 Angiodynamics Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Tumor Ablation Products Offered
10.2.5 Medtronic Recent Development
10.3 Boston Scientific
10.3.1 Boston Scientific Company Information
10.3.2 Boston Scientific Introduction and Business Overview
10.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boston Scientific Tumor Ablation Products Offered
10.3.5 Boston Scientific Recent Development
10.4 Misonix
10.4.1 Misonix Company Information
10.4.2 Misonix Introduction and Business Overview
10.4.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Misonix Tumor Ablation Products Offered
10.4.5 Misonix Recent Development
10.5 Sonacare Medical
10.5.1 Sonacare Medical Company Information
10.5.2 Sonacare Medical Introduction and Business Overview
10.5.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sonacare Medical Tumor Ablation Products Offered
10.5.5 Sonacare Medical Recent Development
10.6 EDAP TMS
10.6.1 EDAP TMS Company Information
10.6.2 EDAP TMS Introduction and Business Overview
10.6.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.6.4 EDAP TMS Tumor Ablation Products Offered
10.6.5 EDAP TMS Recent Development
10.7 Chongqing Haifu Medical
10.7.1 Chongqing Haifu Medical Company Information
10.7.2 Chongqing Haifu Medical Introduction and Business Overview
10.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Chongqing Haifu Medical Tumor Ablation Products Offered
10.7.5 Chongqing Haifu Medical Recent Development
10.8 HealthTronics
10.8.1 HealthTronics Company Information
10.8.2 HealthTronics Introduction and Business Overview
10.8.3 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.8.4 HealthTronics Tumor Ablation Products Offered
10.8.5 HealthTronics Recent Development
10.9 J &J
10.9.1 J &J Company Information
10.9.2 J &J Introduction and Business Overview
10.9.3 J &J Tumor Ablation Sales, Revenue and Gross Margin (2018-2023)
10.9.4 J &J Tumor Ablation Products Offered
10.9.5 J &J Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tumor Ablation Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tumor Ablation Industrial Chain Analysis
11.4 Tumor Ablation Market Dynamics
11.4.1 Tumor Ablation Industry Trends
11.4.2 Tumor Ablation Market Drivers
11.4.3 Tumor Ablation Market Challenges
11.4.4 Tumor Ablation Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tumor Ablation Distributors
12.3 Tumor Ablation Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
